Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Selected clinical trials for PIK3CA in SCC
| Drug | Target(s) | Phase | Identifier* |
|---|---|---|---|
| Buparlisib (BKM120) | Pan-PI3K | II | NCT01297491 |
| I/II | NCT01820325 | ||
| II | NCT01911325 | ||
| II | NCT01833169 | ||
| PX-866 | Pan-PI3K | I/II | NCT01204099 |
| BYL719 | Alpha class I PI3K | I | NCT01219699 |
| Ib/II | NCT01602315 | ||
| Ib | NCT01449058 | ||
Note:
Identifier from ClinicalTrials.gov.
Abbreviations: PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha; SCC, squamous cell carcinoma; PI3K, phosphatidylinositol 3-kinases.
